Regarding the beneficial effect of an IL-6 antagonist (i.e., tocilizumab), a large multicenter study found that weekly injections of tocilizumab over 24 weeks had a favorable effect in decreasing anxiety and depression levels (29). The gene discussed is IL6; the disease is Anxiety.